News | Magnetic Resonance Imaging (MRI) | November 27, 2017

Siemens Healthineers Introduces GOKnee3D MR Application

Novel application reduces scan time for MR imaging of the knee from 20 minutes to 10, enables clinically validated, high-resolution isotropic 3-D knee exam with all relevant contrasts and evaluation in all imaging planes

Siemens Healthineers Introduces GOKnee3D MR Application

November 27, 2017 — At the 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Siemens Healthineers debuted GOKnee3D, a magnetic resonance imaging (MRI) application that drastically shortens the time required to perform comprehensive diagnostic exams of the knee. Currently, a typical knee examination can be roughly 20 minutes. GOKnee3D enables a push-button, high-resolution diagnostic 3-D knee exam in just 10 minutes. The acquisition of high-resolution isotropic 3-D images subsequently allows flexible evaluation of the images in all possible planes, including double oblique and curved planar. Increasing MRI efficiency in this manner is especially important because knee examinations are the third most common type of MRI examination, accounting for 11 percent of all scans.

The volume acquisition of GOKnee3D is based on a CAIPIRINHA SPACE protocol, which enables higher scan speeds and optimal image reconstruction with better signal quality than in previous technologies. Supported by dedicated, high-channel knee coils as well as automated field-of-view adaptation based on machine learning and artificial intelligence, the MR scanner acquires the volume data of the knee joint at the touch of a button.

To develop and clinically validate the technique, Siemens Healthineers collaborated with Johns Hopkins University in Baltimore. “GOKnee3D enables comprehensive evaluation of internal derangement to the knee,” said Jan Fritz, M.D., assistant professor of radiology and radiological sciences at the Johns Hopkins University School of Medicine. “The fully automated CAIPIRINHA SPACE protocol provides high-quality MR imaging in 10 minutes and ensures consistency of image quality and operational efficiency. The high spatial resolution isotropic data sets help to visualize abnormalities with high accuracy, enable reformations of virtually any imaging plane, and create high-quality 3-D-rendered MR images.”

GOKnee3D is U.S. Food and Drug Administration (FDA) 510(k)-pending. It is available as an upgrade for the Magnetom Skyra 3T and Magnetom Aera 1.5T MR scanners, with eventual rollout planned for additional MR scanners.

For more information: www.usa.healthcare.siemens.com

 

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
Konica Minolta Healthcare Announces Autologous Biologics Workshop in Partnership With EmCyte Corp.
News | Ultrasound Imaging | June 12, 2019
Konica Minolta Healthcare announced a new autologous biologics workshop in partnership with EmCyte Corp. The workshop...